Vascepa Capsule
Product Images NDC 52937-101

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Vascepa (NDC 52937-101). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Amarin Pharma Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Vascepa 01)

FDA Label Image

Figure 1 (Vascepa 02)

Figure 1 (Vascepa 02)
This appears to be a table or graph showing the number of patients who experienced an event (with percentages) in a clinical trial comparing a placebo group and a group receiving a medication called VASCEPA. The hazard ratio of the medication is listed as 0.75 with a 95% confidence interval of 0.68 to 0.83. The table also shows the number of patients at risk and the years since randomization. The exact nature of the event being studied is not clear.*
FDA Label Image

Principal Display Panel (240 Capsule Bottle Label)

Principal Display Panel (240 Capsule Bottle Label)
Each capsule of Amarin Pharma's ICOSAPENT ETHYL contains 0.5 gram. The recommended storage temperature for the medicine is between 20° to 25°C (68° to 77°F). For dosage information, please see the package insert. Contact 1-855-VASCEPA (827-2372) for more information.*
FDA Label Image

Principal Display Panel (120 Capsule Bottle Label)

Principal Display Panel (120 Capsule Bottle Label)
Vascepa is a medication containing icosapent ethyl available in capsule form. It is distributed by Amarin Pharma, Inc. in the USA and manufactured for Amarin Pharmaceuticals Ireland Ltd. in Dublin, Ireland. The usual adult dosage is provided in the package insert. It is recommended to store the medication at room temperature between 20° to 25°C (68° to 77°F). For further questions or information, contact 1-855-VASCEPA (827-2372). NDC 52937-001-20. Rev. 02/20.*
FDA Label Image

Principal Display Panel (8 Capsule Blister Carton)

Principal Display Panel (8 Capsule Blister Carton)
This is a prescription drug called Vascepa, with the active ingredient icosapent ethyl. Each capsule contains 1 gram of the drug. The recommended adult dosage is 2 capsules taken twice daily with food, or as directed by a physician. The drug should not be broken open, crushed, dissolved, or chewed. The text also includes information about a sample pack containing 8 capsules, as well as a warning to keep the drug out of reach of children. Additional information can be found in the enclosed Prescribing Information.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.